World's Best Scientists 2026 revealed!
Reinhard E. Voll

Reinhard E. Voll

D-Index & Metrics

Immunology

D-Index
73
Citations
24831
World Ranking
2105
National Ranking
146

Reinhard E. Voll publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Reinhard E. Voll sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 377 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Reinhard E. Voll D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Reinhard E. Voll sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Reinhard E. Voll is affiliated with the University of Freiburg in Germany and has contributed extensively to the fields of Medicine and Immunology and Microbiology, with a total of 225 publications in Medicine and 90 in Immunology and Microbiology. Their research primarily focuses on Immunology, Rheumatology, Infectious Diseases, Genetics, and Neurology as subfields of study.

Key topics addressed in Voll's work include:

  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Autoimmune and Inflammatory Disorders Research
  • Immunodeficiency and Autoimmune Disorders

The scientist has contributed to a range of publication venues, with the most frequent being:

  • Annals of the Rheumatic Diseases (26 publications)
  • Frontiers in Immunology (17 publications)
  • Zeitschrift für Rheumatologie (10 publications)
  • RMD Open (9 publications)
  • Nature Communications (4 publications)

Some recent papers authored or co-authored by Voll include:

  • "The expansion of human T-bet high CD21 low B cells is T cell dependent," 2021, Science Immunology
  • "Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases," 2021, RMD Open
  • "CD20 as a gatekeeper of the resting state of human B cells," 2021, Proceedings of the National Academy of Sciences
  • "Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial," 2024, The Lancet
  • "Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance," 2022, Annals of the Rheumatic Diseases

Frequent co-authors collaborating with Voll include:

  • Nils Venhoff
  • Stephanie Finzel
  • Rebecca Hasseli
  • Bimba F. Hoyer
  • Christof Specker

Best Publications

  • Immunosuppressive effects of apoptotic cells

    Reinhard E. Voll;Martin Herrmann;Edith A. Roth;Christian Stach

  • Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

    Abdul Hakkim;Barbara G. Fürnrohr;Kerstin Amann;Britta Laube

  • IMPAIRED PHAGOCYTOSIS OF APOPTOTIC CELL MATERIAL BY MONOCYTE-DERIVED MACROPHAGES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

    Martin Herrmann;Reinhard E. Voll;Otmar M. Zoller;Manuela Hagenhofer

  • A rapid and simple method for the isolation of apoptotic DNA fragments

    M Herrmann;H M Lorenz;R Voll;M Grünke

  • The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.

    Kirsten Neubert;Silke Meister;Katrin Moser;Florian Weisel

  • Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.

    Irith Baumann;Wasilis Kolowos;Reinhard E. Voll;Bernhard Manger

  • Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products

    Ingrid E. Dumitriu;Paramita Baruah;Barbara Valentinis;Reinhard E. Voll

  • Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE

    Vilma Urbonaviciute;Barbara G. Fürnrohr;Silke Meister;Luis Munoz

  • Extensive immunoglobulin production sensitizes myeloma cells for proteasome inhibition.

    Silke Meister;Ulrich Schubert;Kirsten Neubert;Kai Herrmann

  • The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

    Tobias Alexander;Ramona Sarfert;Jens Klotsche;Anja A. Kühl

  • Clearance deficiency and systemic lupus erythematosus (SLE).

    Udo S. Gaipl;Luis E. Munoz;Gerhard Grossmayer;Kirsten Lauber

  • NF-κB Activation by the Pre-T Cell Receptor Serves as a Selective Survival Signal in T Lymphocyte Development

    Reinhard E Voll;Eijiro Jimi;Roderick J Phillips;Domingo F Barber

  • Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus

    David L. Morris;Yujun Sheng;Yujun Sheng;Yan Zhang;Yong Fei Wang

  • SLE—a disease of clearance deficiency?

    L. E. Munoz;U. S. Gaipl;S. Franz;A. Sheriff

  • Impaired clearance of dying cells in systemic lupus erythematosus

    Udo S. Gaipl;Reinhard E. Voll;Ahmed Sheriff;Sandra Franz

  • Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum

    Ger van Zandbergen;Annalena Bollinger;Alexander Wenzel;Shaden Kamhawi

  • Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.

    Martin Aringer;Frédéric Houssiau;Caroline Gordon;Winfried B Graninger

  • Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation.

    Baiyong Li;Hong Yu;Wei-ping Zheng;Reinhard Voll

  • Sodium Overload and Water Influx Activate the NALP3 Inflammasome

    Christine Schorn;Benjamin Frey;Kirsten Lauber;Christina Janko

  • 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance

    Stefan Uderhardt;Martin Herrmann;Olga V. Oskolkova;Susanne Aschermann

  • Activation of Tumor-specific T Lymphocytes by Radio-Frequency Ablation of the VX2 Hepatoma in Rabbits

    Thaddäus Till Wissniowski;Johannes Hänsler;Daniel Neureiter;Markus Frieser

  • Factors masking HMGB1 in human serum and plasma

    Vilma Urbonaviciute;Barbara G. Fürnrohr;Christian Weber;Martin Haslbeck

Frequent Co-Authors

Martin Herrmann
Martin Herrmann University of Erlangen-Nuremberg
Udo S. Gaipl
Udo S. Gaipl University of Erlangen-Nuremberg
Joachim R. Kalden
Joachim R. Kalden University of Erlangen-Nuremberg
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Marta Rizzi
Marta Rizzi Medical University of Vienna
Ulrich Salzer
Ulrich Salzer University of Freiburg
Benjamin Frey
Benjamin Frey University of Erlangen-Nuremberg
Luis E. Muñoz
Luis E. Muñoz University of Erlangen-Nuremberg
Klaus Warnatz
Klaus Warnatz University of Freiburg
Falk Hiepe
Falk Hiepe Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare fields such as nursing offer diverse career pathways. Many students look for programs that balance quality with manageable coursework; exploring the easiest np program options can help identify suitable online degrees that fit individual learning styles and schedules.

Specializations like psychiatric nursing are also gaining traction, with a focus on mental health challenges. Prospective students should consider the best psychiatric mental health nurse practitioner programs online to ensure strong clinical placements and hands-on experience, crucial for career readiness in this field.

Cost is a significant factor when selecting a program. There are highly regarded, affordable options available, such as those detailed in the cheapest online pmhnp certificate programs article, which can help reduce the financial burden while maintaining quality education.

Completing advanced degrees like a Doctor of Nursing Practice (DNP) opens doors to leadership and specialized roles. Understanding earning potential is equally important—insights into the doctor of nursing practice salary overview can guide career decisions and help set realistic expectations after graduation.

Best Scientists Citing Reinhard E. Voll

Trending Scientists

Recently Published Articles